Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
1,502
Views
2
CrossRef citations to date
0
Altmetric
Articles

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

Mark G. Lebwohla Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
,
Linda Stein Goldb Henry Ford Hospital, Detroit, MI, USA
,
James Q. Del Rossoc JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV, USA
,
Lawrence Greend Department of Dermatology, George Washington University School of Medicine, Washington, DC, USA
&
Abby Jacobsone Ortho Dermatologics, Bridgewater, NJ, USA
Pages 2068-2074 | Received 22 Mar 2021, Accepted 02 Apr 2021, Published online: 16 Jun 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zoe Diana Draelos, Matthew M. Draelos, Tina Lin & Abby Jacobson. (2023) Fixed-combination halobetasol propionate and tazarotene topical lotion decreases TNF-α and IL-17A levels in psoriatic lesions. Journal of Dermatological Treatment 34:1.
Read now

Articles from other publishers (1)

Lyn Guenther, Irina Turchin, Ron Vender, Lorne E. Albrecht, Catherine Maari, Howard Yanofsky & Vimal H. Prajapati. (2024) Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis. Dermatology and Therapy 14:7, pages 1917-1928.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.